Skip to main content

Table 4 Providers prescribing antenatal corticosteroids in several obstetric situations different from a threatened preterm labor

From: Use of antenatal corticosteroids for preterm birth in Latin America: providers knowledge, attitudes and practices

 

El Salvador (N=109)

Mexico (N=59)

Ecuador (N=64)

Uruguay (N=121)

Differences between Countries*

 

n/N

(%)

n/N

(%)

n/N

(%)

n/N

(%)

 

Multiple pregnancy

92/106

(86.8)

33/44

(75.0)

51/59

(86.4)

101/106

(95.3)

- Mexico differs from Uruguay

Preterm premature rupture of membranes

98/106

(92.5)

30/43

(69.8)

46/56

(82.1)

100/106

(94.3)

- Mexico differs from El Salvador and Uruguay

Haemorrhage in the second half of pregnancy

91/106

(85.8)

23/37

(62.2)

38/49

(77.6)

86/106

(81.1)

- No difference between countries

Pre-eclampsia

82/104

(78.8)

22/42

(52.4)

30/47

(63.8)

72/106

(67.9)

- El Salvador differs from Mexico

Intrauterine growth restriction

49/101

(48.5)

17/40

(42.5)

29/48

(60.4)

70/106

(66.0)

- No difference between countries

Previous preterm birth

70/105

(66.7)

24/38

(63.2)

36/52

(69.2)

63/106

(59.4)

- No difference between countries

Upper urinary infection

46/101

(45.5)

16/39

(41.0)

22/45

(48.9)

55/106

(51.9)

- No difference between countries

Hypertension

47/100

(47.0)

16/39

(41.0)

24/44

(54.5)

36/106

(34.0)

- No difference between countries

Diabetes

36/98

(36.7)

10/39

(25.6)

19/45

(42.2)

30/106

(28.3)

- No difference between countries

Lower urinary infection

32/99

(32.3)

16/38

(42.1)

21/44

(47.7)

25/106

(23.6)

- Ecuador differs from Uruguay

Asymptomatic bacteriurua

29/99

(29.3)

8/36

(22.2)

22/43

(51.2)

22/106

(20.8)

- Ecuador differs from Mexico and Uruguay

  1. *The Marascuilo test was used to test the differences between countries.